India  
 
NewsR.in

BioNTech CEO looks for more vaccine production

Video Credit: Reuters Studio - Duration: 01:08s - Published
BioNTech CEO looks for more vaccine production

BioNTech CEO looks for more vaccine production

The chief executive of Germany's BioNTech SE, Ugur Sahin, said the biggest challenge facing it and partner Pfizer Inc now that their COVID-19 vaccine is authorized for use in the United States will be to scale up manufacturing to meet huge demand.


You Might Like


Related videos from verified sources

'India will get 50% of everything...': World's largest vaccine-maker, SII [Video]

'India will get 50% of everything...': World's largest vaccine-maker, SII

Serum Institute of India’s CEO Adar Poonawalla spoke on the Covid-19 vaccine production and roll-out. SII, world's largest vaccine maker, is producing Oxford-Astrazeneca vaccine. SII has applied for..

Credit: HT Digital Content     Duration: 02:53Published
U.S. Orders 100 Million Additional Pfizer Coronavirus Vaccine Doses [Video]

U.S. Orders 100 Million Additional Pfizer Coronavirus Vaccine Doses

Pfizer and BioNTech just announced that the Trump administration has ordered an additional 100 million doses of the coronavirus vaccine. Veuer’s Chandra Lanier has the story.

Credit: Veuer     Duration: 01:02Published
BioNTech CEO Confident That Vaccine Will Work on the New Strain of Coronavirus [Video]

BioNTech CEO Confident That Vaccine Will Work on the New Strain of Coronavirus

BioNTech CEO Confident That Vaccine Will Work on the New Strain of Coronavirus

Credit: Cerise Media English     Duration: 01:02Published